Healthcare institutions claim that the revision of the premerger notification process was unwarranted and detrimental to the industry.

In a significant move, the Federal Trade Commission (FTC) under the leadership of Chair Lina Khan, implemented changes to the Hart-Scott-Rodino (HSR) premerger notification requirements on February 10, 2025. These changes have resulted in a more burdensome filing process for businesses seeking merger clearance.

The new requirements have increased the volume of information required for a proper HSR notification. This means that businesses will need to allocate more resources and time to the merger clearance process. The FTC's own admission states that the changes have also increased the number of documentary attachments needed for an HSR filing.

The changes have made the filing process more complex. In fact, the new requirements have imposed a roughly fourfold increase in the time needed to prepare an HSR filing, according to the FTC. This increased complexity has sparked discussions among businesses and legal experts, who are considering the potential impact on the merger and acquisition landscape.

The changes to the HSR premerger notification requirements were a part of the reforms initiated during the Biden administration. Representative Jerrold Nadler, the chairman of the Congress during that time, played a key role in these reforms.

The FTC, under Lina Khan's leadership during the Biden administration, implemented these changes. The changes were substantial, as acknowledged by the FTC, and have resulted in a substantial shift in the requirements for businesses seeking merger clearance.

These changes are expected to have far-reaching implications for businesses planning mergers and acquisitions. Businesses will need to carefully consider the increased time and resources required for the HSR filing process and adjust their strategies accordingly. It is essential for businesses to stay informed about these changes and seek guidance from legal experts to navigate the new requirements effectively.

Healthcare institutions claim that the revision of the premerger notification process was unwarranted and detrimental to the industry.